Skip to content
DataLookout
Menu

CHIMENCT07947095

Investigating the Effectiveness of Calisda, a Digital Health Intervention for Patients With Menopause Symptoms

StatusNot Yet Recruiting
PhaseNot applicable
SponsorGaia AG
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

29-item Menopause-Specific Quality of Life Questionnaire (MENQOL; 1-week recall) total score
Timeframe: 6 months

Secondary (4)

Hot Flash Related Daily Interference Scale (HFRDIS) total score
Insomnia Severity Index (ISI) total score
Patient Health Questionnaire (PHQ-9) total score
Menopause Rating Scale II (MRS-II) total score

Arms and interventions

calisdaExperimental

Participants will receive access to the digital health intervention calisda in addition to TAU.

Control groupNo intervention

Participants allocated to the control group will receive access to treatment as usual (TAU).

Behavioral: calisda

Sites

1 site in 1 country

  • GAIA AGHamburg, Germany